You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Bladder cancer

Bladder EpiCheck for detecting bladder cancer recurrence

  • Medtech innovation briefing
  • Reference number: MIB293
  • Published:  03 May 2022

Download (PDF)
  • Overview
  • Summary
  • The technology
  • Regulatory information
  • Equality considerations
  • Clinical and technical evidence
  • Expert comments
  • Expert commentators
  • Development of this briefing

Regulatory information

Bladder EpiCheck is CE marked as an in vitro diagnostic (In Vitro Diagnostic Directive [IVDD]; general category).


Next page Equality considerations Previous page The technology
Back to top